Peptide linkers for polypeptide compositions and methods for using same
Disclosed herein are novel peptide linkers and polypeptide compositions comprising the linkers (e.g., chimeric polypeptides) and methods of using the polypeptide compositions. The compositions and methods are particularly useful for targeting/delivering a polypeptide or protein of interest (e.g., a therapeutic polypeptide) to a cell, tissue or organ of interest in order to treat various diseases or disorders (e.g., lysosomal storage disorders).
1. An isolated polypeptide composition comprising:
a) a first peptide;
b) a second peptide; and
c) a linker comprising one or more sequential repeats of the amino acid sequence SEQ ID NO: 1 disposed between said first peptide and said second peptide.
2. The polypeptide composition of claim 1 , wherein said linker comprises three sequential repeats SEQ ID NO: 1.
3. The polypeptide composition of claim 1 , wherein said linker further comprises the amino acid sequence glycine-alanine-proline (GAP) at the C-terminus of SEQ ID NO: 1.
4. The polypeptide composition of claim 1 , wherein said first peptide comprises the amino acid sequence of SEQ ID NO: 4.
5. The polypeptide composition of claim 1 , wherein said second peptide comprises a receptor binding domain.
6. The polypeptide composition of claim 1 , wherein said second peptide comprises the amino acid sequence of SEQ ID NO: 6.
7. The polypeptide composition of claim 1 , wherein said linker comprises the amino acid sequence of SEQ ID NO:2 disposed between said first peptide and said second peptide.
8. An isolated polypeptide linker comprising the amino acid sequence of SEQ ID NO: 1.
9. The polypeptide linker of claim 8 , wherein the linker comprises the amino acid sequence of SEQ ID NO: 2.
10. The polypeptide linker of claim 8 , wherein said linker comprises three sequential repeats of SEQ ID NO: 1.
11. The polypeptide linker of claim 10 , wherein the C-terminus of said polypeptide linker further comprises the amino acid sequence glycine-alanine-proline (GAP).
12. The polypeptide composition of claim 1 , wherein said composition further comprises an acceptable carrier.